Streptozotocin-induced diabetes differentially modifies haloperidol- and γ-hydroxybutyric acid (GHB)-induced catalepsy
- 4 July 2005
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 517 (1-2) , 64-67
- https://doi.org/10.1016/j.ejphar.2005.05.043
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Novel γ-Hydroxybutyric Acid (GHB) Analogs Share Some, but Not All, of the Behavioral Effects of GHB and GABAB Receptor AgonistsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Haloperidol, but not clozapine, produces dramatic catalepsy in Δ9‐THC‐treated rats: possible clinical implicationsBritish Journal of Pharmacology, 2003
- Selective Decreases in Amphetamine Self-Administration and Regulation of Dopamine Transporter Function in Diabetic RatsNeuroendocrinology, 2003
- Food Deprivation Decreases mRNA and Activity of the Rat Dopamine TransporterNeuroendocrinology, 1998
- Changes in the central dopaminergic systems in the streptozotocin-induced diabetic ratsArchives of Pharmacal Research, 1994
- Concentration of Striatal Tyramine and Dopamine Metabolism in Diabetic Rats and Effect of Insulin AdministrationNeuroendocrinology, 1986
- Stereotyped behavior and diabetes mellitus in rats: Reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [–3H]spiroperidol.Behavioral Neuroscience, 1985
- Dopaminergic activity is reduced in diabetic ratsNeuroscience Letters, 1984
- Dopamine Receptor Binding Is Increased in Diabetic RatsScience, 1981
- Further analysis of the resistance of the diabetic rat to d-amphetaminePharmacology Biochemistry and Behavior, 1978